Chair of Immunology
University of Constance, Department of Biology,
P1101, Universitätsstr. 10, D-78457 Konstanz, Germany

Marcus Groettrup
Prof. Dr. rer. nat.
Phone: 0049 - 7531 - 88 2130
(Office: 0049 - 7531 - 88 2254)
Fax: 0049 - 7531 - 88 3102
E-Mail: Marcus.Groettrup@uni-konstanz.de
Cytotoxic T-lymphocytes can detect intracellular antigens which are cut into peptides and presented at the cell surface on MHC class I molecules. The protease which is in charge of fragmenting protein antigens is the proteasome. The proteasome (depicted on the left) is constructed like a cylinder of four stacked rings with seven subunits each. Proteolysis occurs in a proteolytic chamber formed by the two inner rings of b-type subunits. Three of the b-type subunits (called d, MB1, and Z) bear the active site subunits of the proteasome. When a cell is stimulated with the antiviral cytokine interferon-g, three additional proteolytic subunits are strongly induced which take the place of the constitutively expressed active site subunits during proteasome neosynthesis. Moreover, the proteasome regulator PA28a/b is induced through interferon-g. Both, PA28a/b and the exchange of active site subunits changes the cleavage properties of the proteasome and the efficiency of peptide processing for antigen presentation. We are interested in the function of these interferon-g induced changes in proteasome composition and study this both with biochemical techniques and by using a virus model of antigen presentation, the lymphocytic choriomeningitis virus of the mouse.
A second focus of our work is on the functional properties of dendritic cells (DC). DCs act like master switches of the immune response because they are the only cells which are able to activate T cells which have not seen their antigen before. DCs capture antigens in the skin and mucous membranes and carry them into the lymph nodes where the immune response is initiated. We study how viral and bacterial antigens activate DCs with the aim of using DCs as cellular vaccines in immunotherapy against tumors.

  1. Groettrup, M., Soza, A., Eggers, M., Kuehn, L., Dick, T.P., Schild, H., Rammensee, H.-G., Koszinowski, U.H. and Kloetzel, P.-M. (1996) A role for the proteasome regulator PA28a in antigen presentation. Nature 381: 166-168.

  2. Groettrup, M., Standera, S., Stohwasser, R. and Kloetzel, P.-M. (1997) The subunits MECL-1 and LMP2 are mutually required for incorporation into the 20S proteasome. Proc. Natl. Acad. Sci. USA 94: 8970-8975.

  3. Schwarz, K., van den Broek, M., Kostka, S., Kraft, R., Soza, A., Schmidtke, G., Kloetzel, P.-M. and Groettrup, M. (2000) Overexpression of the proteasome subunits LMP2, LMP7, and MECL-1 but not PA28a/b enhances the presentation of an immunodominant lymphocytic choriomeningitis virus T cell epitope. J. Immunol. 165: 768-778.

  4. Dannull, J., Diener, P.-A., Prickler, L., Fürstenberger, G., Cerny, T., Schmid, U., Ackermann, D.K. and Groettrup, M. (2000) Prostate stem cell antigen (PSCA) is a promising candidate for immunotherapy of advanced prostate cancer. Cancer Res. 60: 5522-5528.

  5. Raasi, S., Schmidtke, G. and Groettrup, M. (2001) The ubiquitin like protein FAT10 forms covalent conjugates and induces apoptosis. J. Biol. Chem. 276: 35334-35343.

  6. Macagno, A., Kuehn, L., de Giuli, R. and Groettrup, M. (2001) Pronounced upregulation of the PA28a/b proteasome regulator but little increase in the steady state content of immunoproteasomes during dendritic cell maturation. Eur. J. Immunol. 31: 3271-3280.

  7. Khan, S., van den Broek, M., Schwarz, K., de Giuli, R., Diener, P.-A. and Groettrup, M. (2001) Immunoproteasomes largely replace constitutive proteasomes during an antiviral and antibacterial immune response in the liver. J. Immunol. 167: 6859-6868.

  8. Groettrup, M., van den Broek, M., Schwarz, K., Macagno, A., Khan, S., de Giuli, R. and Schmidtke, G. (2001) Structural plasticity of the proteasome and its function in antigen processing. Crit. Rev. Immunol. 21: 339-359.

  9. Scandella, E., Men, Y., Gillessen, S., Förster, R. and Groettrup, M. (2002) Prostaglandin E2 is a key factor for CCR7 surface expression and migration of monocyte-derived dendritic cells. Blood 100: 1354-1361.

Author: webmaster
created: 09.11.2002
last update: 23.07.2003